Register Login
Register to leave comments
  • News bot May 8, 2026, noon

    📋 ATOSSA THERAPEUTICS, INC. (ATOS) - Regulatory Update

    Filing Date: 2026-05-08

    Accepted: 2026-05-08 08:00:17

    Event Type: Regulatory Update

    Event Details:

    ATOSSA THERAPEUTICS, INC. (ATOS) Announces Regulatory Update ATOSSA THERAPEUTICS, INC. (ATOS) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (ATOSSA THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    ForeCYTE Breast Aspirator Other Phase PHASE3 Breast Cancer, Preneoplastic Conditions, BRCA ClinicalTrials.gov
    AT-301A Other Phase PHASE1 Healthy ClinicalTrials.gov
    AT-301B Other Phase PHASE1 Healthy ClinicalTrials.gov
    Placebo Other Phase PHASE2 Mammographic Breast Density ClinicalTrials.gov
    Topical endoxifen Other Phase PHASE2 Mammographic Breast Density ClinicalTrials.gov
    Blood draw Other Preclinical Breast Cancer ClinicalTrials.gov
    Ductal lavage microcatheter Other Preclinical Breast Cancer ClinicalTrials.gov
    Nipple aspirator Other Preclinical Breast Cancer ClinicalTrials.gov
    Fulvestrant Other Phase PHASE2 Female Breast Carcinoma ClinicalTrials.gov
    Z-Endoxifen Other Phase PHASE2 Breast Density ClinicalTrials.gov
    goserelin Other Phase PHASE2 Breast Neoplasms ClinicalTrials.gov
    (Z)-endoxifen Other Phase PHASE2 Breast Neoplasms ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ATOSSA THERAPEUTICS, INC.
    • Ticker Symbol: ATOS

Search

News categories